ASHLEY ATTAWAY: Open Payments
NPI 1447088026 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 26 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $247 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $186 |
| AstraZeneca Pharmaceuticals LP | 2 | $150 |
| Alnylam Pharmaceuticals Inc. | 5 | $107 |
| ABIOMED | 1 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Novo Nordisk Inc | 2 | $40 |
| BridgeBio Pharma, Inc. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Olympus America Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: REPATHA, FARXIGA, AMVUTTRA, LEQVIO, Wegovy, Attruby, CAMZYOS, iTIND System.
Industry payments across TN — which companies pay providers there.
